Get the latest cancer news and research. Sort by cancer type or read the current headlines to learn what’s happening in the science of cancer detection and treatment, as well as healthy living tips for dealing with cancer.
24
Tikcro Technologies today announced that the United States Department of Health and Human Services has granted orphan drug status to BioCancell's BC-819 drug, currently in Phase I/IIa clinical trials, for its use in treating ovarian cancer.
PharmaGap Inc. is pleased to announce results from the initial testing of its lead cancer drug GAP-107B8 by the U.S. National Cancer Institute (NCI).
An oxygen treatment given to divers with the bends is to be trialled on cancer patients suffering from the side effects of radiotherapy. UK trials will take place in oxygen chambers, including one based at the Spire Hospital in Cardiff, to test the effectiveness of the treatment.
20
A new study finds that young women with early- stage ovarian cancer can preserve future fertility by keeping at least one ovary or the uterus without increasing the risk of dying from the disease. The study is published in the September 15, 2009 issue of Cancer, a peer- reviewed journal of the American Cancer Society.
18
Critical Outcome Technologies Inc. (COTI) announced important positive results today from a series of experiments carried out at a prominent American cancer research facility. The experiments were designed; first, to estimate the oral maximum tolerated dose (MTD) for COTI- 2; second, to evaluate the effectiveness of oral COTI-2 alone and third, to compare the effectiveness of oral COTI-2 plus Doxil(R) (doxorubicin HCl) to that of Doxil alone.
14
The human papillomavirus vaccine is effective in protecting women ages 25-45 not already infected with the virus. A study in the June 6 issue of the Lancet pointed out that while HPV infection occurs in most women within five to 10 years of first sexual experience, all women remain at risk for infection, which is linked to most types of cervical cancer.
13
Risk of human papillomavirus (HPV)-associated cancers is greater for people living with AIDS and increases with increasing immunosuppression, according to a new study published online July 31 in the Journal of the National Cancer Institute.
The Society of Gynecologic Oncologists (SGO) has published the first in a series of four papers on a variety of cervical cancer issues and topics that were the focus of its Forum The Future Strategies for Cervical Cancer Prevention: What Do We Need to Do Now to Prepare, held last September in Chicago, Illinois.
Many women at high risk for breast or ovarian cancer are choosing to undergo surgery as a precautionary measure to decrease their cancer risk, according to a report in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
Exiqon announced the nationwide launch of the ArQive Registry, a prospective, observational study designed to strengthen the supporting data for the Oncotech Extreme Drug Resistance (EDR) Assay and to collect data to help develop novel molecular assays (miRNA) within three key tumor types: colon, lung and ovarian.
We care about your feedback. Let us know how we can improve your CancerCompass experience.